These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 20139360)

  • 1. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
    Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo.
    Dong LH; Li L; Song Y; Duan ZL; Sun SG; Lin YL; Miao SB; Yin YJ; Shu YN; Li H; Chen P; Zhao LL; Han M
    Circ Res; 2015 Sep; 117(8):684-94. PubMed ID: 26291555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling.
    Klutho PJ; Pennington SM; Scott JA; Wilson KM; Gu SX; Doddapattar P; Xie L; Venema AN; Zhu LJ; Chauhan AK; Lentz SR; Grumbach IM
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2594-604. PubMed ID: 26449752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.
    Wang L; Zheng J; Bai X; Liu B; Liu CJ; Xu Q; Zhu Y; Wang N; Kong W; Wang X
    Circ Res; 2009 Mar; 104(5):688-98. PubMed ID: 19168437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.
    Torella D; Gasparri C; Ellison GM; Curcio A; Leone A; Vicinanza C; Galuppo V; Mendicino I; Sacco W; Aquila I; Surace FC; Luposella M; Stillo G; Agosti V; Cosentino C; Avvedimento EV; Indolfi C
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2015-25. PubMed ID: 19783773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinase pathway mediated by cAMP/PKA signaling.
    Liu D; Huang Y; Bu D; Liu AD; Holmberg L; Jia Y; Tang C; Du J; Jin H
    Cell Death Dis; 2014 May; 5(5):e1251. PubMed ID: 24853429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.
    Wu H; Cheng XW; Hu L; Takeshita K; Hu C; Du Q; Li X; Zhu E; Huang Z; Yisireyili M; Zhao G; Piao L; Inoue A; Jiang H; Lei Y; Zhang X; Liu S; Dai Q; Kuzuya M; Shi GP; Murohara T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1549-57. PubMed ID: 27365406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
    Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
    Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway.
    Lee HM; Jeon BH; Won KJ; Lee CK; Park TK; Choi WS; Bae YM; Kim HS; Lee SK; Park SH; Irani K; Kim B
    Circ Res; 2009 Jan; 104(2):219-27, 5p following 227. PubMed ID: 19038866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms.
    Xu XL; Ling DY; Zhu QY; Fan WJ; Zhang W
    Eur J Pharmacol; 2013 Jan; 698(1-3):370-8. PubMed ID: 23178522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
    Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with alpha(7)beta(1) integrin.
    Wang L; Zheng J; Du Y; Huang Y; Li J; Liu B; Liu CJ; Zhu Y; Gao Y; Xu Q; Kong W; Wang X
    Circ Res; 2010 Feb; 106(3):514-25. PubMed ID: 20019333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
    Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
    J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
    Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of interleukin-1 receptor-associated kinase-1 in vascular smooth muscle cell proliferation and neointimal formation after rat carotid injury.
    Jain M; Singh A; Singh V; Barthwal MK
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1445-55. PubMed ID: 25908764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.